Antibiotics Market Trends

  • Report ID: 4465
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Antibiotics Market Trends

Growth Drivers

  • Growing Prevalence of Respiratory Diseases - The respiratory system is a group of organs that regulates breathing. The lungs are the system's main organ, and it also consists of the pharynx, larynx, trachea, nasal tube, oral cavity, pharynx, and bronchi and bronchioles. Respiratory diseases are one of the leading causes of death worldwide. These diseases need a preferred dose of antibiotics to control the further spread of bacteria. Therefore, growing prevalence of respiratory diseases is fueling up the antibiotics market growth. As per the World Health Organization statistics, globally, nearly 262 million individuals have been suffering from asthma.
  • Surge in Drug Combinations Over Mono-Therapy – It was observed in a clinical study that a database for antifungal therapy has nearly 5,517 medicines in 8,129 combinations that have been evaluated against 240 strains, yielding 491,126 samples.
  • Escalation in Urinary Tract Infections (UTIs) – For instance, every year, more than 8 million patients with urinary tract infections (UTIs) seek medical treatment. About 61% of women and 13% of men are predicted to get at least one UTI in their lives.
  • Boost in Global Burden of Bacterial Skin Diseases – Globally, the age-standardized estimated incidence of bacterial skin diseases was reached around 161 million for males and 133 million for females in 2019.
  • Growing Number of Older-Aged Population - According to the statistics of World Health Organization, the global population of people aged 60 and up is projected to increase from 1 billion in 2020 to 1.4 billion by 2030.

Challenges

  • Side Effects Associated with Antibiotics - Antibiotic side effects can include allergic reactions and severe, sometimes fatal diarrhea brought on by the bacterium Clostridium difficile (C. diff). Additionally, antibiotics may conflict with other medications.
  • Stringent Regulatory Procedures
  • Escalation in Antibiotic Resistance

Antibiotics Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~8%

Market Size in Base Year (2022)

~ USD 43 Billion

Market Size in Forecast Year (2035)

~ USD 108 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)

Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)

Base Year

2024

Forecast Year

2025-2037

CAGR

8.2%

Market Size in Base Year (2024)

USD 50.55 billion

Market Size in Forecast Year (2037)

USD 142.07 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4465
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of antibiotics is estimated at USD 53.91 billion.

The antibiotics market size was valued at USD 50.55 billion in 2024 and is expected to cross USD 142.07 billion by the end of 2037, expanding at more than 8.2% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of respiratory diseases, surge in drug combinations over mono-therapy, escalation in urinary tract infections (UTIs) will drive the market growth.

Asia Pacific is anticipated to hold majority industry share by 2037, backed by growing prevalence of infectious diseases, increasing consumption of antibiotics by regional population, significantly growing population, and growing healthcare expenditure in the region.

The major players in the market include F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Bristol-Myers Squibb Company, Teva Pharmaceuticals Industries Ltd., Pfizer Inc., Abbott Laboratories, Merck & Co., Inc., Lupin Limited, Melinta Therapeutics, LLC, Bayer AG.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample